ClinicalTrials.gg
RecruitingNCT05715424Updated Apr 9, 2024

Community Intervention and Demonstration Area Construction

An interventional study of Six interventions for children and adolescents in Myopia and Refractive Errors, sponsored by Anhui Medical University. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2024-04-09.

Sponsored by Anhui Medical University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Dec 2022; still recruiting 3 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,000,000
Allocation
Randomized
Sex
All
01

Study summary

The objective of this intervention study was to understand the visual health status of nearly one million children and adolescents in ten provinces in China, and then to conduct intervention and evaluate the effect of intervention measures with the development of myopia as the outcome indicator. The study will be conducted in the form of a stepped intervention and will answer the following questions.

Current China children and adolescent's vision health, including the different degrees of myopia prevalence, and farsightedness reserve status. To evaluate the implementation and effect of eight appropriate technologies and six interventions developed in this study, to reduce the incidence of myopia among children and adolescents in China, to achieve the purpose of nationwide application.

In the early stage of this study, a baseline survey will be conducted on participants. In the middle stage, participants will be required to adjust the seat height regularly and increase the time for outdoor activities, etc. In the later stage, intervention measures will be evaluated based on the overall research situation to consider national promotion.

02

Conditions studied

  • Myopia
  • Refractive Errors
03

In context

Myopia

1,159 studies on the registry are indexed under Myopia; 225 are open to participants now.

This study's planned enrollment of 1,000,000 is above the median of 78 across 923 interventional studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

Anhui Medical University is the lead sponsor of 104 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ● Kindergarten kids.

    • Grade of 1 to 6 in elementary schools.
    • Grade of 1 to 3 in middle schools.
    • Grade of 1 to 3 in high schools.
    • Sign the .

Exclusion criteria

Exclusion Criteria:

  • ●Visual defect or other eye diseases.

    • wearing orthokeratology; refractive surgery history.
    • Not considered suitable for inclusion in the study by the investigator.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
1,000,000 participants (estimated)

Study arms

  • Experimental
    Cluster A

    The study population (school-based) was divided into four clusters.Each cluster will receive the same intervention.and one cluster was randomly selected as Cluster A. The intervention was administered at month 6 and monitored for two years.

    Other: Six interventions for children and adolescents

  • Experimental
    Cluster B

    The study population (school-based) was divided into four clusters. Each cluster will receive the same intervention.and one cluster was randomly selected as Cluster B. The intervention was administered at month 12 and monitored for one and a half years.

    Other: Six interventions for children and adolescents

  • Experimental
    Cluster C

    The study population (school-based) was divided into four clusters.Each cluster will receive the same intervention. and one cluster was randomly selected as Cluster C. The intervention was administered at month 18 and monitored for a continuous period of one year.

    Other: Six interventions for children and adolescents

  • Experimental
    Cluster D

    The study population (school-based) was divided into four clusters.Each cluster will receive the same intervention.and one cluster was randomly selected as Cluster D. The intervention was implemented at month 18 and an evaluation of the effect of the intervention was performed.

    Other: Six interventions for children and adolescents

Interventions

  • OtherSix interventions for children and adolescents

    * Vision Health Record Establishment and Myopia Risk Assessment. * Evaluation of vision care behavior and development of reasonable eye use behavior. * Health education for teachers and parents. * Action to improve the reading and writing environment at home and school. * One hour of outdoor activities in and out of school during the day. * Myopia grading management and medical correction action.

06

What researchers measure

Primary outcomes

  1. Changes in questionnaire survey

    Questionnaires based on myopia prevention and control for children and adolescents, including a questionnaire on myopia in children and adolescents.

    Time frame: Baseline, 6 months, 1 year, 1.5 years, 2 years

  2. Changes in uncorrected vision within two years

    Uncorrected visual acuity (UCVA) was measured for the right eye, then the left eye, with a E Standard Logarithm Vision Acuity Chart (GB11533-2011) in 5-grade notation (5- LogMAR), with illumination of the chart around 500lx. If one of the eyes UCVA was less than 5.0, then tests with combined lenses were conducted among the poor eye-sighted for confirming the types of ametropia (normal, myopia, hyperopia or other eye diseases).All the measurements were recorded.

    Time frame: Baseline, 6 months, 1 year, 1.5 years, 2 years

  3. Changes in visual acuity in computer optometry

    Optometry Automated computerized optometry is performed by an optometrist. Automatic optometry instrument using desktop computer automatic optometry, equipment requirements should conform to the "ISO10342-2010 Ophthalmic instruments: Optometry" provisions.

    Time frame: Baseline, 6 months, 1 year, 1.5 years, 2 years

  4. Changes in visual acuity during dilated pupil optometry

    Between 5% and 10% of the participants were selected for Dilated pupil optometry.

    Time frame: Baseline, 6 months, 1 year, 1.5 years, 2 years

Secondary outcomes

  1. Eye protection diary

    Daily questionnaire based on the development of myopia prevention and control in children and adolescents.

    Time frame: Three months.

  2. Qualitative interview

    Based on the interview outline on myopia prevention and control, some randomly selected students, parents, teachers and related departments were investigated.

    Time frame: Baseline, 1 year, 2 years

07

Study locations

1 of 1 sites recruiting
  • Anqing myopia scene
    Anqing, Anhui 246000, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2022 (actual). Primary completion is estimated for Dec 2024, 24 months after the start.

Of 200 non-industry interventional studies with no phase under Myopia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 24 months is close to that.

Counting every sponsor, half of 434 studies reached it within 14 months; a quarter within 3 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2022
First posted
Feb 8, 2023
StartActual
Dec 1, 2022
Primary completionEst.
Dec 2024
CompletionEst.
Dec 2024
Last update
Apr 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05715424
Collaborators
Shanghai Eye Disease Prevention and Treatment Center, Beijing Center for Disease Control and Prevention
Responsible party
Fangbiao Tao (Professor and Dean, Anhui Medical University, Anhui Medical University) — Principal investigator
First posted
Feb 8, 2023
Start date
Dec 1, 2022
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Apr 9, 2024

Study contacts

FangBiao Tao, Professor
Contact
vipur8@outlook.com
+86 19966513010
FangBiao Tao, Professor
study director · Anhui Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion